Solco Biomedical Co (XKRX:043100) Ending Cash Position : ₩10,045 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Solco Biomedical Co Ending Cash Position?

Solco Biomedical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩10,045 Mil.

Solco Biomedical Co's quarterly Ending Cash Position increased from Sep. 2023 (₩2,281 Mil) to Dec. 2023 (₩2,354 Mil) and increased from Dec. 2023 (₩2,354 Mil) to Mar. 2024 (₩10,045 Mil).

Solco Biomedical Co's annual Ending Cash Position declined from Dec. 2021 (₩5,156 Mil) to Dec. 2022 (₩3,692 Mil) and declined from Dec. 2022 (₩3,692 Mil) to Dec. 2023 (₩2,354 Mil).

Solco Biomedical Co Ending Cash Position Historical Data

The historical data trend for Solco Biomedical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solco Biomedical Co Ending Cash Position Chart

Solco Biomedical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2,852.59

2,465.36

5,156.10

3,691.88

2,353.96

Solco Biomedical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,864.23	2,450.51	2,281.08	2,353.96	10,045.39

Solco Biomedical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Solco Biomedical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3891.883	+	-1537.92
	=	2,354

Solco Biomedical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2353.963	+	7691.429
	=	10,045

Solco Biomedical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Solco Biomedical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Solco Biomedical Co (XKRX:043100) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solco Biomedical Co Ltd (XKRX:043100) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

34-6 Keumam-ri, Seotan-myeon, Gyeonggi-do, Pyeongtaek, KOR, 451-852

Website

http://www.solco.co.kr

Solco Biomedical Co Ltd operates in the medical devices industry in South Korea. The products offered by the company include dressing and tissue forceps, scissors, needle holders, intestinal forceps, self-retaining retractors, hooks, and knife handles.

Solco Biomedical Co (XKRX:043100) Headlines

No Headlines